Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 8,790 | 16,212 | 20,139 | 29,731 | 27,011 | 30,476 | 30,947 |
| EBITDA | 933 | 2,330 | 3,311 | 4,827 | 1,820 | 2,154 | 2,381 |
| Net profit | 909 | 2,278 | 2,865 | 4,054 | 1,267 | 1,555 | 1,784 |
| Total assets | 3,368 | 6,759 | 8,247 | 11,140 | 10,921 | 10,376 | 12,163 |
| n (companies reporting) | 3 | 3 | 5 | 5 | 5 | 5 | 5 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Katastropis Meditsinis … | 2,603 | 6,224 | 6,424 | 7,765 | 6,542 | 5,880 | 6,484 |
| Vorldvaid Klinikal Trai… | 2,957 | 3,374 | 3,746 | 4,068 | 4,870 | 5,731 | 6,399 |
| G Da G | 3,230 | 6,614 | 9,969 | 12,837 | 9,733 | 10,380 | 6,277 |
| Parmaseutikal Riserch E… | — | — | 0 | 2,652 | 2,929 | 3,391 | 5,960 |
| Ken Volkeris Sakhelobis… | — | — | 0 | 2,410 | 2,937 | 5,094 | 5,828 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2018–FY2020 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.